HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (21)
2023
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
2021
-
Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study
Journal of Clinical Oncology, Vol. 39, Núm. 28, pp. 3118-3127
2020
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11
-
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292
2019
-
Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
WORLD JOURNAL OF CLINICAL ONCOLOGY, Vol. 10, Núm. 10, pp. 318-339
-
Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1020-1030
2018
-
A guide to treating gait impairment with prolonged-release fampridine (Fampyra ® ) in patients with multiple sclerosis
Neurologia
-
Paediatric research in Spain: Challenges and priorities. INVEST-AEP Platform
Anales de Pediatria, Vol. 89, Núm. 5, pp. 314.e1-314.e6
2017
-
Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial
Journal of Bone and Mineral Research, Vol. 32, Núm. 5, pp. 1040-1051
-
Revisión de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunión Post-ECTRIMS (II)
Revista de Neurologia, Vol. 65, Núm. 2, pp. 75-84
-
Revisión de las novedades del XXXII congreso ectrims 2016, presentadas en la ix reunión post-ectrims (I)
Revista de Neurologia, Vol. 65, Núm. 1, pp. 31-40
2016
-
Effects of teriparatide compared with risedronate on recovery after pertrochanteric hip fracture results of a randomized, active-controlled, double-blind clinical trial at 26 weeks
Journal of Bone and Joint Surgery - American Volume, Vol. 98, Núm. 22, pp. 1868-1878
-
Respuesta al tratamiento con interferón beta en pacientes con esclerosis múltiple. Validación del Rio Score
Revista de Neurologia, Vol. 63, Núm. 4, pp. 145-150
2015
-
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e147
2014
2012
-
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases
British Journal of Haematology, Vol. 159, Núm. 2, pp. 164-171
2011
-
Revisión de las novedades presentadas en el XXVI Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) (II)
Revista de Neurologia, Vol. 52, Núm. 5, pp. 289-299
2010
-
Liraglutida en el tratamiento de la diabetes tipo 2:: recomendaciones para una mejor selección de los pacientes, desde una visión multidisciplinar
Avances en Diabetologia, Vol. 26, Núm. 4, pp. 226-234
-
Liraglutide in the treatment of Type 2 diabetes: Clinical data and practical considerations for its use
Expert Review of Endocrinology and Metabolism, Vol. 5, Núm. 6, pp. 799-807